Arrowhead Pharmaceuticals (ARWR) Tax Rate (2021 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Tax Rate came in at 0.01% in Q1 2026, down 48.0% YoY from 0.01% in Q1 2025, and down 104.96% on a QoQ basis from 0.1% in Q4 2025.
Analysis
Arrowhead Pharmaceuticals (ARWR) Tax Rate (2021 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 6 years of Tax Rate data on file, last reported at 0.01% in Q1 2026.
- Quarterly Tax Rate fell 48.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.78% (down 622.0% YoY) and the FY2025 annual result came in at 41.56%, up 4111.0% from the prior year.
- Tax Rate fell to 0.01% in Q1 2026, from 0.1% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 55.37% in Q3 2025 to a low of 4.61% in Q3 2022.
- A 5-year average of 4.64% and a median of 0.01% in 2026 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate tumbled 460 bps — and 2025, when it soared 5568 bps.
- Tracing ARWR's Tax Rate over 5 years: stood at 4.61% in 2022, then soared by 152 bps to 2.39% in 2023, then plunged by 102 bps to 0.06% in 2024, then soared by 274 bps to 0.1% in 2025, then plunged by 105 bps to 0.01% in 2026.
- The last three Tax Rate figures came in at 0.01% (Q1 2026), 0.1% (Q4 2025), and 55.37% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - | -0.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.10% |
| Sep 30, 2025 | 55.37% |
| Jun 30, 2025 | 0.24% |
| Mar 31, 2025 | 0.47% |
| Dec 31, 2024 | -0.06% |
| Sep 30, 2024 | -0.32% |
| Dec 31, 2023 | 2.39% |
| Sep 30, 2023 | -1.86% |
| Jun 30, 2023 | -0.72% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -4.61% |
| Sep 30, 2021 | 0.00% |